Becton, Dickinson and Company, BD Biosciences recalls BD FACSLyric 3L 10C with FACSuite Clinical Software v1.1.1, catalog number 662878 BD FACSLyric is a high-performance fl…
- Recall date
- January 2, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-0792-2019
- FDA classification
- Class III
- Brand / firm
- Becton, Dickinson and Company, BD Biosciences
- Sold / distributed
- US Distribution in MD.
Why it was recalled
A customer site was identified to have three FACSLyric IVD systems with FACSuite clinical v1.1.1 installed on a computer workstation with windows 10 operating system (OS). Windows 10 OS is not a released configuration for clinical use. It is released for research use only.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
BD FACSLyric 3L 10C with FACSuite Clinical Software v1.1.1, catalog number 662878 BD FACSLyric is a high-performance flow cytometer designed to support both routine clinical analysis and research for the identification, quantification, and characterization of cells in support of cell analysis. BD FACSuite software is loaded onto an adjacent PC workstation and is used to operate the instrument, acquire samples, and analyze data. Quality control performance, tracking, and reporting are streamlined and automated. Routine tasks such as daily cleaning and shutdown can be programmed to occur automatically. The BD FACSuite clinical software allows users to run BD IVD assays.
Get recall alerts
Free email alert whenever Becton, Dickinson and Company, BD Biosciences has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Becton, Dickinson and Company, BD Biosciences